Location History:
- Newton Center, MA (US) (1987 - 1995)
- Fox Place, MA (US) (2001)
- Newton, MA (US) (1991 - 2005)
- Newton Centre, MA (US) (1984 - 2010)
Company Filing History:
25 out of 1,210 
2 out of 5,452 
1 out of 3,385 
Years Active: 1984-2010
Title: The Innovative Contributions of Stuart F. Schlossman
Introduction
Stuart F. Schlossman is a prominent inventor based in Newton Centre, MA, whose groundbreaking work has led to the development of 27 patents. His contributions primarily focus on therapeutic approaches targeting diseases associated with CD26, showcasing the intersection of innovation and medical advancements.
Latest Patents
Among his recent patents, Schlossman has developed therapeutic methods that involve administering anti-CD26 monoclonal antibodies for the prevention and treatment of cancers and immune diseases. These innovations describe various types of anti-CD26 antibodies and detail modes of administration, offering promising pathways for addressing complex health issues linked to CD26 expression.
Career Highlights
Stuart F. Schlossman has had an impressive career, working with esteemed institutions such as the Dana-Farber Cancer Institute and the University of Texas System. His work within these organizations has not only advanced scientific understanding but has also contributed to the practical application of his inventions in real-world settings, ultimately benefiting patient outcomes.
Collaborations
Collaboration has played a significant role in Schlossman's career. He has worked alongside notable colleagues such as Chikao Morimoto and Paul J. Anderson, fostering an environment of creativity and shared knowledge that has propelled their research efforts forward. These partnerships highlight the value of teamwork in innovation and the development of effective therapies.
Conclusion
Stuart F. Schlossman's innovative work exemplifies the impact that targeted research can have on medicine. His extensive patent portfolio and collaborations with leading institutions showcase the importance of intellectual contributions in addressing significant health challenges. Through his dedication and ingenuity, Schlossman continues to pave the way for future advancements in medical therapies.